Index IndexTemplate TemplateConstraints Constraints

DPM Map for eba_tC_34.02

AddressLabelMetricsData TypePeriod Typeeba_dim:APReba_dim:BASeba_dim:CPSeba_dim:CRMeba_dim:MCCeba_dim:MCGeba_dim:MCYeba_dim:MDEeba_dim:PRPeba_dim:TRI
r0.0010eba_a2.root/Number of counterpartieseba_met:ii174xbrli:integerItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/AN/AN/Aeba_PL:x10eba_TR:x1
r0.0020eba_a2.root/Number of transactionseba_met:ii624xbrli:integerItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/AN/AN/Aeba_PL:x10eba_TR:x1
r0.0030eba_a2.root/Notional amountseba_met:mi170xbrli:monetaryItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/AN/AN/Aeba_PL:x10eba_TR:x1
r0.0040eba_a2.root/Current market value (CMV), positiveeba_met:mi533xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/AN/AN/Aeba_PL:x10eba_TR:x1
r0.0050eba_a2.root/Current market value (CMV), negativeeba_met:mi740xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/AN/AN/Aeba_PL:x10eba_TR:x1
r0.0060eba_a2.root/Variation margin (VM), receivedeba_met:mi780xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/Aeba_MC:x409N/AN/Aeba_PL:x10eba_TR:x1
r0.0070eba_a2.root/Variation margin (VM), postedeba_met:mi780xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/Aeba_MC:x415N/AN/AN/Aeba_PL:x10eba_TR:x1
r0.0080eba_a2.root/Net independent collateral amount (NICA), receivedeba_met:mi781xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/Aeba_MC:x409N/AN/Aeba_PL:x10eba_TR:x1
r0.0090eba_a2.root/Net independent collateral amount (NICA), postedeba_met:mi781xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/Aeba_MC:x415N/AN/AN/Aeba_PL:x10eba_TR:x1
r0.0100eba_a2.root/Replacement cost (RC)eba_met:mi650xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/AN/AN/Aeba_PL:x10eba_TR:x1
r0.0110eba_a2.root/Potential future exposure (PFE)eba_met:mi430xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/AN/AN/Aeba_PL:x10eba_TR:x1
r0.0120eba_a2.root/Current exposureeba_met:mi782xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/AN/AN/Aeba_PL:x10eba_TR:x1
r0.0130eba_a2.root/EEPEeba_met:mi783xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/AN/AN/Aeba_PL:x10eba_TR:x1
r0.0140eba_a2.root/Alpha used for computing regulatory exposure valueeba_met:mi784xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/AN/AN/Aeba_PL:x10eba_TR:x1
r0.0150eba_a2.root/Exposure value pre-CRMeba_met:mi118xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/AN/AN/Aeba_PL:x10eba_TR:x1
r0.0160eba_a2.root/Exposure value post-CRMeba_met:mi116xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/AN/AN/Aeba_PL:x10eba_TR:x1
r0.0170eba_a2.root/Exposure valueeba_met:mi119xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/AN/AN/Aeba_PL:x10eba_TR:x1
r0.0180eba_a2.root/Positions treated with the CR standardised approacheba_met:mi119xbrli:monetaryItemTypeinstanteba_AP:x42eba_BA:x9eba_CT:x81N/AN/AN/AN/AN/Aeba_PL:x10eba_TR:x1
r0.0190eba_a2.root/Positions treated with the CR IRB approacheba_met:mi119xbrli:monetaryItemTypeinstanteba_AP:x27eba_BA:x9eba_CT:x81N/AN/AN/AN/AN/Aeba_PL:x10eba_TR:x1
r0.0200eba_a2.root/Risk weighted exposure amountseba_met:mi793xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/AN/AN/Aeba_PL:x10eba_TR:x1
r0.0210eba_a2.root/Positions treated with the CR standardised approacheba_met:mi793xbrli:monetaryItemTypeinstanteba_AP:x42eba_BA:x9eba_CT:x81N/AN/AN/AN/AN/Aeba_PL:x10eba_TR:x1
r0.0220eba_a2.root/Positions treated with the CR IRB approacheba_met:mi793xbrli:monetaryItemTypeinstanteba_AP:x27eba_BA:x9eba_CT:x81N/AN/AN/AN/AN/Aeba_PL:x10eba_TR:x1
0010.0010Original exposure method (for derivatives)/Number of counterpartieseba_met:ii174xbrli:integerItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x38eba_PL:x10eba_TR:x1
0010.0020Original exposure method (for derivatives)/Number of transactionseba_met:ii624xbrli:integerItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x38eba_PL:x10eba_TR:x1
0010.0030Original exposure method (for derivatives)/Notional amountseba_met:mi170xbrli:monetaryItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x38eba_PL:x10eba_TR:x1
0010.0040Original exposure method (for derivatives)/Current market value (CMV), positiveeba_met:mi533xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x38eba_PL:x10eba_TR:x1
0010.0050Original exposure method (for derivatives)/Current market value (CMV), negativeeba_met:mi740xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x38eba_PL:x10eba_TR:x1
0010.0060Original exposure method (for derivatives)/Variation margin (VM), receivedeba_met:mi780xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/Aeba_MC:x409eba_MC:x99eba_AP:x38eba_PL:x10eba_TR:x1
0010.0070Original exposure method (for derivatives)/Variation margin (VM), postedeba_met:mi780xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/Aeba_MC:x415N/Aeba_MC:x99eba_AP:x38eba_PL:x10eba_TR:x1
0010.0080Original exposure method (for derivatives)/Net independent collateral amount (NICA), receivedeba_met:mi781xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/Aeba_MC:x409eba_MC:x99eba_AP:x38eba_PL:x10eba_TR:x1
0010.0090Original exposure method (for derivatives)/Net independent collateral amount (NICA), postedeba_met:mi781xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/Aeba_MC:x415N/Aeba_MC:x99eba_AP:x38eba_PL:x10eba_TR:x1
0010.0100Original exposure method (for derivatives)/Replacement cost (RC)eba_met:mi650xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x38eba_PL:x10eba_TR:x1
0010.0110Original exposure method (for derivatives)/Potential future exposure (PFE)eba_met:mi430xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x38eba_PL:x10eba_TR:x1
0010.0120Original exposure method (for derivatives)/Current exposureeba_met:mi782xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x38eba_PL:x10eba_TR:x1
0010.0130Original exposure method (for derivatives)/EEPEeba_met:mi783xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x38eba_PL:x10eba_TR:x1
0010.0140Original exposure method (for derivatives)/Alpha used for computing regulatory exposure valueeba_met:mi784xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x38eba_PL:x10eba_TR:x1
0010.0150Original exposure method (for derivatives)/Exposure value pre-CRMeba_met:mi118xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x38eba_PL:x10eba_TR:x1
0010.0160Original exposure method (for derivatives)/Exposure value post-CRMeba_met:mi116xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x38eba_PL:x10eba_TR:x1
0010.0170Original exposure method (for derivatives)/Exposure valueeba_met:mi119xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x38eba_PL:x10eba_TR:x1
0010.0180Original exposure method (for derivatives)/Positions treated with the CR standardised approacheba_met:mi119xbrli:monetaryItemTypeinstanteba_AP:x42eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x38eba_PL:x10eba_TR:x1
0010.0190Original exposure method (for derivatives)/Positions treated with the CR IRB approacheba_met:mi119xbrli:monetaryItemTypeinstanteba_AP:x27eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x38eba_PL:x10eba_TR:x1
0010.0200Original exposure method (for derivatives)/Risk weighted exposure amountseba_met:mi793xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x38eba_PL:x10eba_TR:x1
0010.0210Original exposure method (for derivatives)/Positions treated with the CR standardised approacheba_met:mi793xbrli:monetaryItemTypeinstanteba_AP:x42eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x38eba_PL:x10eba_TR:x1
0010.0220Original exposure method (for derivatives)/Positions treated with the CR IRB approacheba_met:mi793xbrli:monetaryItemTypeinstanteba_AP:x27eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x38eba_PL:x10eba_TR:x1
0020.0010Simplified SA-CCR (for derivatives)/Number of counterpartieseba_met:ii174xbrli:integerItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x183eba_PL:x10eba_TR:x1
0020.0020Simplified SA-CCR (for derivatives)/Number of transactionseba_met:ii624xbrli:integerItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x183eba_PL:x10eba_TR:x1
0020.0030Simplified SA-CCR (for derivatives)/Notional amountseba_met:mi170xbrli:monetaryItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x183eba_PL:x10eba_TR:x1
0020.0040Simplified SA-CCR (for derivatives)/Current market value (CMV), positiveeba_met:mi533xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x183eba_PL:x10eba_TR:x1
0020.0050Simplified SA-CCR (for derivatives)/Current market value (CMV), negativeeba_met:mi740xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x183eba_PL:x10eba_TR:x1
0020.0060Simplified SA-CCR (for derivatives)/Variation margin (VM), receivedeba_met:mi780xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/Aeba_MC:x409eba_MC:x99eba_AP:x183eba_PL:x10eba_TR:x1
0020.0070Simplified SA-CCR (for derivatives)/Variation margin (VM), postedeba_met:mi780xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/Aeba_MC:x415N/Aeba_MC:x99eba_AP:x183eba_PL:x10eba_TR:x1
0020.0080Simplified SA-CCR (for derivatives)/Net independent collateral amount (NICA), receivedeba_met:mi781xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/Aeba_MC:x409eba_MC:x99eba_AP:x183eba_PL:x10eba_TR:x1
0020.0090Simplified SA-CCR (for derivatives)/Net independent collateral amount (NICA), postedeba_met:mi781xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/Aeba_MC:x415N/Aeba_MC:x99eba_AP:x183eba_PL:x10eba_TR:x1
0020.0100Simplified SA-CCR (for derivatives)/Replacement cost (RC)eba_met:mi650xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x183eba_PL:x10eba_TR:x1
0020.0110Simplified SA-CCR (for derivatives)/Potential future exposure (PFE)eba_met:mi430xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x183eba_PL:x10eba_TR:x1
0020.0120Simplified SA-CCR (for derivatives)/Current exposureeba_met:mi782xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x183eba_PL:x10eba_TR:x1
0020.0130Simplified SA-CCR (for derivatives)/EEPEeba_met:mi783xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x183eba_PL:x10eba_TR:x1
0020.0140Simplified SA-CCR (for derivatives)/Alpha used for computing regulatory exposure valueeba_met:mi784xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x183eba_PL:x10eba_TR:x1
0020.0150Simplified SA-CCR (for derivatives)/Exposure value pre-CRMeba_met:mi118xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x183eba_PL:x10eba_TR:x1
0020.0160Simplified SA-CCR (for derivatives)/Exposure value post-CRMeba_met:mi116xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x183eba_PL:x10eba_TR:x1
0020.0170Simplified SA-CCR (for derivatives)/Exposure valueeba_met:mi119xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x183eba_PL:x10eba_TR:x1
0020.0180Simplified SA-CCR (for derivatives)/Positions treated with the CR standardised approacheba_met:mi119xbrli:monetaryItemTypeinstanteba_AP:x42eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x183eba_PL:x10eba_TR:x1
0020.0190Simplified SA-CCR (for derivatives)/Positions treated with the CR IRB approacheba_met:mi119xbrli:monetaryItemTypeinstanteba_AP:x27eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x183eba_PL:x10eba_TR:x1
0020.0200Simplified SA-CCR (for derivatives)/Risk weighted exposure amountseba_met:mi793xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x183eba_PL:x10eba_TR:x1
0020.0210Simplified SA-CCR (for derivatives)/Positions treated with the CR standardised approacheba_met:mi793xbrli:monetaryItemTypeinstanteba_AP:x42eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x183eba_PL:x10eba_TR:x1
0020.0220Simplified SA-CCR (for derivatives)/Positions treated with the CR IRB approacheba_met:mi793xbrli:monetaryItemTypeinstanteba_AP:x27eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x183eba_PL:x10eba_TR:x1
0030.0010SA-CCR (for derivatives)/Number of counterpartieseba_met:ii174xbrli:integerItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x184eba_PL:x10eba_TR:x1
0030.0020SA-CCR (for derivatives)/Number of transactionseba_met:ii624xbrli:integerItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x184eba_PL:x10eba_TR:x1
0030.0030SA-CCR (for derivatives)/Notional amountseba_met:mi170xbrli:monetaryItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x184eba_PL:x10eba_TR:x1
0030.0040SA-CCR (for derivatives)/Current market value (CMV), positiveeba_met:mi533xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x184eba_PL:x10eba_TR:x1
0030.0050SA-CCR (for derivatives)/Current market value (CMV), negativeeba_met:mi740xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x184eba_PL:x10eba_TR:x1
0030.0060SA-CCR (for derivatives)/Variation margin (VM), receivedeba_met:mi780xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/Aeba_MC:x409eba_MC:x99eba_AP:x184eba_PL:x10eba_TR:x1
0030.0070SA-CCR (for derivatives)/Variation margin (VM), postedeba_met:mi780xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/Aeba_MC:x415N/Aeba_MC:x99eba_AP:x184eba_PL:x10eba_TR:x1
0030.0080SA-CCR (for derivatives)/Net independent collateral amount (NICA), receivedeba_met:mi781xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/Aeba_MC:x409eba_MC:x99eba_AP:x184eba_PL:x10eba_TR:x1
0030.0090SA-CCR (for derivatives)/Net independent collateral amount (NICA), postedeba_met:mi781xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/Aeba_MC:x415N/Aeba_MC:x99eba_AP:x184eba_PL:x10eba_TR:x1
0030.0100SA-CCR (for derivatives)/Replacement cost (RC)eba_met:mi650xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x184eba_PL:x10eba_TR:x1
0030.0110SA-CCR (for derivatives)/Potential future exposure (PFE)eba_met:mi430xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x184eba_PL:x10eba_TR:x1
0030.0120SA-CCR (for derivatives)/Current exposureeba_met:mi782xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x184eba_PL:x10eba_TR:x1
0030.0130SA-CCR (for derivatives)/EEPEeba_met:mi783xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x184eba_PL:x10eba_TR:x1
0030.0140SA-CCR (for derivatives)/Alpha used for computing regulatory exposure valueeba_met:mi784xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x184eba_PL:x10eba_TR:x1
0030.0150SA-CCR (for derivatives)/Exposure value pre-CRMeba_met:mi118xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x184eba_PL:x10eba_TR:x1
0030.0160SA-CCR (for derivatives)/Exposure value post-CRMeba_met:mi116xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x184eba_PL:x10eba_TR:x1
0030.0170SA-CCR (for derivatives)/Exposure valueeba_met:mi119xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x184eba_PL:x10eba_TR:x1
0030.0180SA-CCR (for derivatives)/Positions treated with the CR standardised approacheba_met:mi119xbrli:monetaryItemTypeinstanteba_AP:x42eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x184eba_PL:x10eba_TR:x1
0030.0190SA-CCR (for derivatives)/Positions treated with the CR IRB approacheba_met:mi119xbrli:monetaryItemTypeinstanteba_AP:x27eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x184eba_PL:x10eba_TR:x1
0030.0200SA-CCR (for derivatives)/Risk weighted exposure amountseba_met:mi793xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x184eba_PL:x10eba_TR:x1
0030.0210SA-CCR (for derivatives)/Positions treated with the CR standardised approacheba_met:mi793xbrli:monetaryItemTypeinstanteba_AP:x42eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x184eba_PL:x10eba_TR:x1
0030.0220SA-CCR (for derivatives)/Positions treated with the CR IRB approacheba_met:mi793xbrli:monetaryItemTypeinstanteba_AP:x27eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x99eba_AP:x184eba_PL:x10eba_TR:x1
0040.0010IMM (for derivatives and SFTS)/Number of counterpartieseba_met:ii174xbrli:integerItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/Aeba_MC:x110eba_AP:x185eba_PL:x10eba_TR:x1
0040.0020IMM (for derivatives and SFTS)/Number of transactionseba_met:ii624xbrli:integerItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/Aeba_MC:x110eba_AP:x185eba_PL:x10eba_TR:x1
0040.0030IMM (for derivatives and SFTS)/Notional amountseba_met:mi170xbrli:monetaryItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/Aeba_MC:x110eba_AP:x185eba_PL:x10eba_TR:x1
0040.0040IMM (for derivatives and SFTS)/Current market value (CMV), positiveeba_met:mi533xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x110eba_AP:x185eba_PL:x10eba_TR:x1
0040.0050IMM (for derivatives and SFTS)/Current market value (CMV), negativeeba_met:mi740xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x110eba_AP:x185eba_PL:x10eba_TR:x1
0040.0060IMM (for derivatives and SFTS)/Variation margin (VM), receivedeba_met:mi780xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/Aeba_MC:x409eba_MC:x110eba_AP:x185eba_PL:x10eba_TR:x1
0040.0070IMM (for derivatives and SFTS)/Variation margin (VM), postedeba_met:mi780xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/Aeba_MC:x415N/Aeba_MC:x110eba_AP:x185eba_PL:x10eba_TR:x1
0040.0080IMM (for derivatives and SFTS)/Net independent collateral amount (NICA), receivedeba_met:mi781xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/Aeba_MC:x409eba_MC:x110eba_AP:x185eba_PL:x10eba_TR:x1
0040.0090IMM (for derivatives and SFTS)/Net independent collateral amount (NICA), postedeba_met:mi781xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/Aeba_MC:x415N/Aeba_MC:x110eba_AP:x185eba_PL:x10eba_TR:x1
0040.0100IMM (for derivatives and SFTS)/Replacement cost (RC)eba_met:mi650xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x110eba_AP:x185eba_PL:x10eba_TR:x1
0040.0110IMM (for derivatives and SFTS)/Potential future exposure (PFE)eba_met:mi430xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x110eba_AP:x185eba_PL:x10eba_TR:x1
0040.0120IMM (for derivatives and SFTS)/Current exposureeba_met:mi782xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x110eba_AP:x185eba_PL:x10eba_TR:x1
0040.0130IMM (for derivatives and SFTS)/EEPEeba_met:mi783xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x110eba_AP:x185eba_PL:x10eba_TR:x1
0040.0140IMM (for derivatives and SFTS)/Alpha used for computing regulatory exposure valueeba_met:mi784xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x110eba_AP:x185eba_PL:x10eba_TR:x1
0040.0150IMM (for derivatives and SFTS)/Exposure value pre-CRMeba_met:mi118xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x110eba_AP:x185eba_PL:x10eba_TR:x1
0040.0160IMM (for derivatives and SFTS)/Exposure value post-CRMeba_met:mi116xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x110eba_AP:x185eba_PL:x10eba_TR:x1
0040.0170IMM (for derivatives and SFTS)/Exposure valueeba_met:mi119xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x110eba_AP:x185eba_PL:x10eba_TR:x1
0040.0180IMM (for derivatives and SFTS)/Positions treated with the CR standardised approacheba_met:mi119xbrli:monetaryItemTypeinstanteba_AP:x42eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x110eba_AP:x185eba_PL:x10eba_TR:x1
0040.0190IMM (for derivatives and SFTS)/Positions treated with the CR IRB approacheba_met:mi119xbrli:monetaryItemTypeinstanteba_AP:x27eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x110eba_AP:x185eba_PL:x10eba_TR:x1
0040.0200IMM (for derivatives and SFTS)/Risk weighted exposure amountseba_met:mi793xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x110eba_AP:x185eba_PL:x10eba_TR:x1
0040.0210IMM (for derivatives and SFTS)/Positions treated with the CR standardised approacheba_met:mi793xbrli:monetaryItemTypeinstanteba_AP:x42eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x110eba_AP:x185eba_PL:x10eba_TR:x1
0040.0220IMM (for derivatives and SFTS)/Positions treated with the CR IRB approacheba_met:mi793xbrli:monetaryItemTypeinstanteba_AP:x27eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x110eba_AP:x185eba_PL:x10eba_TR:x1
0050.0010Securities financing transactions netting sets/Number of counterpartieseba_met:ii174xbrli:integerItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/Aeba_MC:x311eba_AP:x185eba_PL:x10eba_TR:x1
0050.0020Securities financing transactions netting sets/Number of transactionseba_met:ii624xbrli:integerItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/Aeba_MC:x311eba_AP:x185eba_PL:x10eba_TR:x1
0050.0030Securities financing transactions netting sets/Notional amountseba_met:mi170xbrli:monetaryItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/Aeba_MC:x311eba_AP:x185eba_PL:x10eba_TR:x1
0050.0040Securities financing transactions netting sets/Current market value (CMV), positiveeba_met:mi533xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x311eba_AP:x185eba_PL:x10eba_TR:x1
0050.0050Securities financing transactions netting sets/Current market value (CMV), negativeeba_met:mi740xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x311eba_AP:x185eba_PL:x10eba_TR:x1
0050.0060Securities financing transactions netting sets/Variation margin (VM), receivedeba_met:mi780xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/Aeba_MC:x409eba_MC:x311eba_AP:x185eba_PL:x10eba_TR:x1
0050.0070Securities financing transactions netting sets/Variation margin (VM), postedeba_met:mi780xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/Aeba_MC:x415N/Aeba_MC:x311eba_AP:x185eba_PL:x10eba_TR:x1
0050.0080Securities financing transactions netting sets/Net independent collateral amount (NICA), receivedeba_met:mi781xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/Aeba_MC:x409eba_MC:x311eba_AP:x185eba_PL:x10eba_TR:x1
0050.0090Securities financing transactions netting sets/Net independent collateral amount (NICA), postedeba_met:mi781xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/Aeba_MC:x415N/Aeba_MC:x311eba_AP:x185eba_PL:x10eba_TR:x1
0050.0100Securities financing transactions netting sets/Replacement cost (RC)eba_met:mi650xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x311eba_AP:x185eba_PL:x10eba_TR:x1
0050.0110Securities financing transactions netting sets/Potential future exposure (PFE)eba_met:mi430xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x311eba_AP:x185eba_PL:x10eba_TR:x1
0050.0120Securities financing transactions netting sets/Current exposureeba_met:mi782xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x311eba_AP:x185eba_PL:x10eba_TR:x1
0050.0130Securities financing transactions netting sets/EEPEeba_met:mi783xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x311eba_AP:x185eba_PL:x10eba_TR:x1
0050.0140Securities financing transactions netting sets/Alpha used for computing regulatory exposure valueeba_met:mi784xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x311eba_AP:x185eba_PL:x10eba_TR:x1
0050.0150Securities financing transactions netting sets/Exposure value pre-CRMeba_met:mi118xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x311eba_AP:x185eba_PL:x10eba_TR:x1
0050.0160Securities financing transactions netting sets/Exposure value post-CRMeba_met:mi116xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x311eba_AP:x185eba_PL:x10eba_TR:x1
0050.0170Securities financing transactions netting sets/Exposure valueeba_met:mi119xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x311eba_AP:x185eba_PL:x10eba_TR:x1
0050.0180Securities financing transactions netting sets/Positions treated with the CR standardised approacheba_met:mi119xbrli:monetaryItemTypeinstanteba_AP:x42eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x311eba_AP:x185eba_PL:x10eba_TR:x1
0050.0190Securities financing transactions netting sets/Positions treated with the CR IRB approacheba_met:mi119xbrli:monetaryItemTypeinstanteba_AP:x27eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x311eba_AP:x185eba_PL:x10eba_TR:x1
0050.0200Securities financing transactions netting sets/Risk weighted exposure amountseba_met:mi793xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x311eba_AP:x185eba_PL:x10eba_TR:x1
0050.0210Securities financing transactions netting sets/Positions treated with the CR standardised approacheba_met:mi793xbrli:monetaryItemTypeinstanteba_AP:x42eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x311eba_AP:x185eba_PL:x10eba_TR:x1
0050.0220Securities financing transactions netting sets/Positions treated with the CR IRB approacheba_met:mi793xbrli:monetaryItemTypeinstanteba_AP:x27eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x311eba_AP:x185eba_PL:x10eba_TR:x1
0060.0010Derivatives and long settlement transactions netting sets/Number of counterpartieseba_met:ii174xbrli:integerItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/Aeba_MC:x100eba_AP:x185eba_PL:x10eba_TR:x1
0060.0020Derivatives and long settlement transactions netting sets/Number of transactionseba_met:ii624xbrli:integerItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/Aeba_MC:x100eba_AP:x185eba_PL:x10eba_TR:x1
0060.0030Derivatives and long settlement transactions netting sets/Notional amountseba_met:mi170xbrli:monetaryItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/Aeba_MC:x100eba_AP:x185eba_PL:x10eba_TR:x1
0060.0040Derivatives and long settlement transactions netting sets/Current market value (CMV), positiveeba_met:mi533xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x100eba_AP:x185eba_PL:x10eba_TR:x1
0060.0050Derivatives and long settlement transactions netting sets/Current market value (CMV), negativeeba_met:mi740xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x100eba_AP:x185eba_PL:x10eba_TR:x1
0060.0060Derivatives and long settlement transactions netting sets/Variation margin (VM), receivedeba_met:mi780xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/Aeba_MC:x409eba_MC:x100eba_AP:x185eba_PL:x10eba_TR:x1
0060.0070Derivatives and long settlement transactions netting sets/Variation margin (VM), postedeba_met:mi780xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/Aeba_MC:x415N/Aeba_MC:x100eba_AP:x185eba_PL:x10eba_TR:x1
0060.0080Derivatives and long settlement transactions netting sets/Net independent collateral amount (NICA), receivedeba_met:mi781xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/Aeba_MC:x409eba_MC:x100eba_AP:x185eba_PL:x10eba_TR:x1
0060.0090Derivatives and long settlement transactions netting sets/Net independent collateral amount (NICA), postedeba_met:mi781xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/Aeba_MC:x415N/Aeba_MC:x100eba_AP:x185eba_PL:x10eba_TR:x1
0060.0100Derivatives and long settlement transactions netting sets/Replacement cost (RC)eba_met:mi650xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x100eba_AP:x185eba_PL:x10eba_TR:x1
0060.0110Derivatives and long settlement transactions netting sets/Potential future exposure (PFE)eba_met:mi430xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x100eba_AP:x185eba_PL:x10eba_TR:x1
0060.0120Derivatives and long settlement transactions netting sets/Current exposureeba_met:mi782xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x100eba_AP:x185eba_PL:x10eba_TR:x1
0060.0130Derivatives and long settlement transactions netting sets/EEPEeba_met:mi783xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x100eba_AP:x185eba_PL:x10eba_TR:x1
0060.0140Derivatives and long settlement transactions netting sets/Alpha used for computing regulatory exposure valueeba_met:mi784xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x100eba_AP:x185eba_PL:x10eba_TR:x1
0060.0150Derivatives and long settlement transactions netting sets/Exposure value pre-CRMeba_met:mi118xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x100eba_AP:x185eba_PL:x10eba_TR:x1
0060.0160Derivatives and long settlement transactions netting sets/Exposure value post-CRMeba_met:mi116xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x100eba_AP:x185eba_PL:x10eba_TR:x1
0060.0170Derivatives and long settlement transactions netting sets/Exposure valueeba_met:mi119xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x100eba_AP:x185eba_PL:x10eba_TR:x1
0060.0180Derivatives and long settlement transactions netting sets/Positions treated with the CR standardised approacheba_met:mi119xbrli:monetaryItemTypeinstanteba_AP:x42eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x100eba_AP:x185eba_PL:x10eba_TR:x1
0060.0190Derivatives and long settlement transactions netting sets/Positions treated with the CR IRB approacheba_met:mi119xbrli:monetaryItemTypeinstanteba_AP:x27eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x100eba_AP:x185eba_PL:x10eba_TR:x1
0060.0200Derivatives and long settlement transactions netting sets/Risk weighted exposure amountseba_met:mi793xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x100eba_AP:x185eba_PL:x10eba_TR:x1
0060.0210Derivatives and long settlement transactions netting sets/Positions treated with the CR standardised approacheba_met:mi793xbrli:monetaryItemTypeinstanteba_AP:x42eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x100eba_AP:x185eba_PL:x10eba_TR:x1
0060.0220Derivatives and long settlement transactions netting sets/Positions treated with the CR IRB approacheba_met:mi793xbrli:monetaryItemTypeinstanteba_AP:x27eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x100eba_AP:x185eba_PL:x10eba_TR:x1
0070.0010From contractual cross-product netting sets/Number of counterpartieseba_met:ii174xbrli:integerItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/Aeba_MC:x310eba_AP:x185eba_PL:x10eba_TR:x1
0070.0020From contractual cross-product netting sets/Number of transactionseba_met:ii624xbrli:integerItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/Aeba_MC:x310eba_AP:x185eba_PL:x10eba_TR:x1
0070.0030From contractual cross-product netting sets/Notional amountseba_met:mi170xbrli:monetaryItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/Aeba_MC:x310eba_AP:x185eba_PL:x10eba_TR:x1
0070.0040From contractual cross-product netting sets/Current market value (CMV), positiveeba_met:mi533xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x310eba_AP:x185eba_PL:x10eba_TR:x1
0070.0050From contractual cross-product netting sets/Current market value (CMV), negativeeba_met:mi740xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x310eba_AP:x185eba_PL:x10eba_TR:x1
0070.0060From contractual cross-product netting sets/Variation margin (VM), receivedeba_met:mi780xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/Aeba_MC:x409eba_MC:x310eba_AP:x185eba_PL:x10eba_TR:x1
0070.0070From contractual cross-product netting sets/Variation margin (VM), postedeba_met:mi780xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/Aeba_MC:x415N/Aeba_MC:x310eba_AP:x185eba_PL:x10eba_TR:x1
0070.0080From contractual cross-product netting sets/Net independent collateral amount (NICA), receivedeba_met:mi781xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/Aeba_MC:x409eba_MC:x310eba_AP:x185eba_PL:x10eba_TR:x1
0070.0090From contractual cross-product netting sets/Net independent collateral amount (NICA), postedeba_met:mi781xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/Aeba_MC:x415N/Aeba_MC:x310eba_AP:x185eba_PL:x10eba_TR:x1
0070.0100From contractual cross-product netting sets/Replacement cost (RC)eba_met:mi650xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x310eba_AP:x185eba_PL:x10eba_TR:x1
0070.0110From contractual cross-product netting sets/Potential future exposure (PFE)eba_met:mi430xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x310eba_AP:x185eba_PL:x10eba_TR:x1
0070.0120From contractual cross-product netting sets/Current exposureeba_met:mi782xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x310eba_AP:x185eba_PL:x10eba_TR:x1
0070.0130From contractual cross-product netting sets/EEPEeba_met:mi783xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x310eba_AP:x185eba_PL:x10eba_TR:x1
0070.0140From contractual cross-product netting sets/Alpha used for computing regulatory exposure valueeba_met:mi784xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x310eba_AP:x185eba_PL:x10eba_TR:x1
0070.0150From contractual cross-product netting sets/Exposure value pre-CRMeba_met:mi118xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x310eba_AP:x185eba_PL:x10eba_TR:x1
0070.0160From contractual cross-product netting sets/Exposure value post-CRMeba_met:mi116xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x310eba_AP:x185eba_PL:x10eba_TR:x1
0070.0170From contractual cross-product netting sets/Exposure valueeba_met:mi119xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x310eba_AP:x185eba_PL:x10eba_TR:x1
0070.0180From contractual cross-product netting sets/Positions treated with the CR standardised approacheba_met:mi119xbrli:monetaryItemTypeinstanteba_AP:x42eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x310eba_AP:x185eba_PL:x10eba_TR:x1
0070.0190From contractual cross-product netting sets/Positions treated with the CR IRB approacheba_met:mi119xbrli:monetaryItemTypeinstanteba_AP:x27eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x310eba_AP:x185eba_PL:x10eba_TR:x1
0070.0200From contractual cross-product netting sets/Risk weighted exposure amountseba_met:mi793xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x310eba_AP:x185eba_PL:x10eba_TR:x1
0070.0210From contractual cross-product netting sets/Positions treated with the CR standardised approacheba_met:mi793xbrli:monetaryItemTypeinstanteba_AP:x42eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x310eba_AP:x185eba_PL:x10eba_TR:x1
0070.0220From contractual cross-product netting sets/Positions treated with the CR IRB approacheba_met:mi793xbrli:monetaryItemTypeinstanteba_AP:x27eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x310eba_AP:x185eba_PL:x10eba_TR:x1
0080.0010Financial collateral simple method (for SFTS)/Number of counterpartieseba_met:ii174xbrli:integerItemTypeinstantN/Aeba_BA:x17eba_CT:x81eba_CP:x13N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0080.0020Financial collateral simple method (for SFTS)/Number of transactionseba_met:ii624xbrli:integerItemTypeinstantN/Aeba_BA:x17eba_CT:x81eba_CP:x13N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0080.0030Financial collateral simple method (for SFTS)/Notional amountseba_met:mi170xbrli:monetaryItemTypeinstantN/Aeba_BA:x17eba_CT:x81eba_CP:x13N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0080.0040Financial collateral simple method (for SFTS)/Current market value (CMV), positiveeba_met:mi533xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x13N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0080.0050Financial collateral simple method (for SFTS)/Current market value (CMV), negativeeba_met:mi740xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x13N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0080.0060Financial collateral simple method (for SFTS)/Variation margin (VM), receivedeba_met:mi780xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x13N/Aeba_MC:x409eba_MC:x306N/Aeba_PL:x10eba_TR:x1
0080.0070Financial collateral simple method (for SFTS)/Variation margin (VM), postedeba_met:mi780xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x13eba_MC:x415N/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0080.0080Financial collateral simple method (for SFTS)/Net independent collateral amount (NICA), receivedeba_met:mi781xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x13N/Aeba_MC:x409eba_MC:x306N/Aeba_PL:x10eba_TR:x1
0080.0090Financial collateral simple method (for SFTS)/Net independent collateral amount (NICA), postedeba_met:mi781xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x13eba_MC:x415N/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0080.0100Financial collateral simple method (for SFTS)/Replacement cost (RC)eba_met:mi650xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x13N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0080.0110Financial collateral simple method (for SFTS)/Potential future exposure (PFE)eba_met:mi430xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x13N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0080.0120Financial collateral simple method (for SFTS)/Current exposureeba_met:mi782xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x13N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0080.0130Financial collateral simple method (for SFTS)/EEPEeba_met:mi783xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x13N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0080.0140Financial collateral simple method (for SFTS)/Alpha used for computing regulatory exposure valueeba_met:mi784xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x13N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0080.0150Financial collateral simple method (for SFTS)/Exposure value pre-CRMeba_met:mi118xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x13N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0080.0160Financial collateral simple method (for SFTS)/Exposure value post-CRMeba_met:mi116xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x13N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0080.0170Financial collateral simple method (for SFTS)/Exposure valueeba_met:mi119xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x13N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0080.0180Financial collateral simple method (for SFTS)/Positions treated with the CR standardised approacheba_met:mi119xbrli:monetaryItemTypeinstanteba_AP:x42eba_BA:x9eba_CT:x81eba_CP:x13N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0080.0190Financial collateral simple method (for SFTS)/Positions treated with the CR IRB approacheba_met:mi119xbrli:monetaryItemTypeinstanteba_AP:x27eba_BA:x9eba_CT:x81eba_CP:x13N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0080.0200Financial collateral simple method (for SFTS)/Risk weighted exposure amountseba_met:mi793xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x13N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0080.0210Financial collateral simple method (for SFTS)/Positions treated with the CR standardised approacheba_met:mi793xbrli:monetaryItemTypeinstanteba_AP:x42eba_BA:x9eba_CT:x81eba_CP:x13N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0080.0220Financial collateral simple method (for SFTS)/Positions treated with the CR IRB approacheba_met:mi793xbrli:monetaryItemTypeinstanteba_AP:x27eba_BA:x9eba_CT:x81eba_CP:x13N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0090.0010Financial collateral comprehensive method (for SFTS)/Number of counterpartieseba_met:ii174xbrli:integerItemTypeinstantN/Aeba_BA:x17eba_CT:x81eba_CP:x11N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0090.0020Financial collateral comprehensive method (for SFTS)/Number of transactionseba_met:ii624xbrli:integerItemTypeinstantN/Aeba_BA:x17eba_CT:x81eba_CP:x11N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0090.0030Financial collateral comprehensive method (for SFTS)/Notional amountseba_met:mi170xbrli:monetaryItemTypeinstantN/Aeba_BA:x17eba_CT:x81eba_CP:x11N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0090.0040Financial collateral comprehensive method (for SFTS)/Current market value (CMV), positiveeba_met:mi533xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x11N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0090.0050Financial collateral comprehensive method (for SFTS)/Current market value (CMV), negativeeba_met:mi740xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x11N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0090.0060Financial collateral comprehensive method (for SFTS)/Variation margin (VM), receivedeba_met:mi780xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x11N/Aeba_MC:x409eba_MC:x306N/Aeba_PL:x10eba_TR:x1
0090.0070Financial collateral comprehensive method (for SFTS)/Variation margin (VM), postedeba_met:mi780xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x11eba_MC:x415N/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0090.0080Financial collateral comprehensive method (for SFTS)/Net independent collateral amount (NICA), receivedeba_met:mi781xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x11N/Aeba_MC:x409eba_MC:x306N/Aeba_PL:x10eba_TR:x1
0090.0090Financial collateral comprehensive method (for SFTS)/Net independent collateral amount (NICA), postedeba_met:mi781xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x11eba_MC:x415N/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0090.0100Financial collateral comprehensive method (for SFTS)/Replacement cost (RC)eba_met:mi650xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x11N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0090.0110Financial collateral comprehensive method (for SFTS)/Potential future exposure (PFE)eba_met:mi430xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x11N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0090.0120Financial collateral comprehensive method (for SFTS)/Current exposureeba_met:mi782xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x11N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0090.0130Financial collateral comprehensive method (for SFTS)/EEPEeba_met:mi783xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x11N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0090.0140Financial collateral comprehensive method (for SFTS)/Alpha used for computing regulatory exposure valueeba_met:mi784xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x11N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0090.0150Financial collateral comprehensive method (for SFTS)/Exposure value pre-CRMeba_met:mi118xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x11N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0090.0160Financial collateral comprehensive method (for SFTS)/Exposure value post-CRMeba_met:mi116xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x11N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0090.0170Financial collateral comprehensive method (for SFTS)/Exposure valueeba_met:mi119xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x11N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0090.0180Financial collateral comprehensive method (for SFTS)/Positions treated with the CR standardised approacheba_met:mi119xbrli:monetaryItemTypeinstanteba_AP:x42eba_BA:x9eba_CT:x81eba_CP:x11N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0090.0190Financial collateral comprehensive method (for SFTS)/Positions treated with the CR IRB approacheba_met:mi119xbrli:monetaryItemTypeinstanteba_AP:x27eba_BA:x9eba_CT:x81eba_CP:x11N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0090.0200Financial collateral comprehensive method (for SFTS)/Risk weighted exposure amountseba_met:mi793xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x11N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0090.0210Financial collateral comprehensive method (for SFTS)/Positions treated with the CR standardised approacheba_met:mi793xbrli:monetaryItemTypeinstanteba_AP:x42eba_BA:x9eba_CT:x81eba_CP:x11N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0090.0220Financial collateral comprehensive method (for SFTS)/Positions treated with the CR IRB approacheba_met:mi793xbrli:monetaryItemTypeinstanteba_AP:x27eba_BA:x9eba_CT:x81eba_CP:x11N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0100.0010VAR for SFTS/Number of counterpartieseba_met:ii174xbrli:integerItemTypeinstantN/Aeba_BA:x17eba_CT:x81eba_CP:x46N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0100.0020VAR for SFTS/Number of transactionseba_met:ii624xbrli:integerItemTypeinstantN/Aeba_BA:x17eba_CT:x81eba_CP:x46N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0100.0030VAR for SFTS/Notional amountseba_met:mi170xbrli:monetaryItemTypeinstantN/Aeba_BA:x17eba_CT:x81eba_CP:x46N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0100.0040VAR for SFTS/Current market value (CMV), positiveeba_met:mi533xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x46N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0100.0050VAR for SFTS/Current market value (CMV), negativeeba_met:mi740xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x46N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0100.0060VAR for SFTS/Variation margin (VM), receivedeba_met:mi780xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x46N/Aeba_MC:x409eba_MC:x306N/Aeba_PL:x10eba_TR:x1
0100.0070VAR for SFTS/Variation margin (VM), postedeba_met:mi780xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x46eba_MC:x415N/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0100.0080VAR for SFTS/Net independent collateral amount (NICA), receivedeba_met:mi781xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x46N/Aeba_MC:x409eba_MC:x306N/Aeba_PL:x10eba_TR:x1
0100.0090VAR for SFTS/Net independent collateral amount (NICA), postedeba_met:mi781xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x46eba_MC:x415N/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0100.0100VAR for SFTS/Replacement cost (RC)eba_met:mi650xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x46N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0100.0110VAR for SFTS/Potential future exposure (PFE)eba_met:mi430xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x46N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0100.0120VAR for SFTS/Current exposureeba_met:mi782xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x46N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0100.0130VAR for SFTS/EEPEeba_met:mi783xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x46N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0100.0140VAR for SFTS/Alpha used for computing regulatory exposure valueeba_met:mi784xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x46N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0100.0150VAR for SFTS/Exposure value pre-CRMeba_met:mi118xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x46N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0100.0160VAR for SFTS/Exposure value post-CRMeba_met:mi116xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x46N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0100.0170VAR for SFTS/Exposure valueeba_met:mi119xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x46N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0100.0180VAR for SFTS/Positions treated with the CR standardised approacheba_met:mi119xbrli:monetaryItemTypeinstanteba_AP:x42eba_BA:x9eba_CT:x81eba_CP:x46N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0100.0190VAR for SFTS/Positions treated with the CR IRB approacheba_met:mi119xbrli:monetaryItemTypeinstanteba_AP:x27eba_BA:x9eba_CT:x81eba_CP:x46N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0100.0200VAR for SFTS/Risk weighted exposure amountseba_met:mi793xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81eba_CP:x46N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0100.0210VAR for SFTS/Positions treated with the CR standardised approacheba_met:mi793xbrli:monetaryItemTypeinstanteba_AP:x42eba_BA:x9eba_CT:x81eba_CP:x46N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0100.0220VAR for SFTS/Positions treated with the CR IRB approacheba_met:mi793xbrli:monetaryItemTypeinstanteba_AP:x27eba_BA:x9eba_CT:x81eba_CP:x46N/AN/Aeba_MC:x306N/Aeba_PL:x10eba_TR:x1
0110.0010Total/Number of counterpartieseba_met:ii174xbrli:integerItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/Aeba_MC:x110N/Aeba_PL:x10eba_TR:x1
0110.0020Total/Number of transactionseba_met:ii624xbrli:integerItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/Aeba_MC:x110N/Aeba_PL:x10eba_TR:x1
0110.0030Total/Notional amountseba_met:mi170xbrli:monetaryItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/Aeba_MC:x110N/Aeba_PL:x10eba_TR:x1
0110.0040Total/Current market value (CMV), positiveeba_met:mi533xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x110N/Aeba_PL:x10eba_TR:x1
0110.0050Total/Current market value (CMV), negativeeba_met:mi740xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x110N/Aeba_PL:x10eba_TR:x1
0110.0060Total/Variation margin (VM), receivedeba_met:mi780xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/Aeba_MC:x409eba_MC:x110N/Aeba_PL:x10eba_TR:x1
0110.0070Total/Variation margin (VM), postedeba_met:mi780xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/Aeba_MC:x415N/Aeba_MC:x110N/Aeba_PL:x10eba_TR:x1
0110.0080Total/Net independent collateral amount (NICA), receivedeba_met:mi781xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/Aeba_MC:x409eba_MC:x110N/Aeba_PL:x10eba_TR:x1
0110.0090Total/Net independent collateral amount (NICA), postedeba_met:mi781xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/Aeba_MC:x415N/Aeba_MC:x110N/Aeba_PL:x10eba_TR:x1
0110.0100Total/Replacement cost (RC)eba_met:mi650xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x110N/Aeba_PL:x10eba_TR:x1
0110.0110Total/Potential future exposure (PFE)eba_met:mi430xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x110N/Aeba_PL:x10eba_TR:x1
0110.0120Total/Current exposureeba_met:mi782xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x110N/Aeba_PL:x10eba_TR:x1
0110.0130Total/EEPEeba_met:mi783xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x110N/Aeba_PL:x10eba_TR:x1
0110.0140Total/Alpha used for computing regulatory exposure valueeba_met:mi784xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x110N/Aeba_PL:x10eba_TR:x1
0110.0150Total/Exposure value pre-CRMeba_met:mi118xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x110N/Aeba_PL:x10eba_TR:x1
0110.0160Total/Exposure value post-CRMeba_met:mi116xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x110N/Aeba_PL:x10eba_TR:x1
0110.0170Total/Exposure valueeba_met:mi119xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x110N/Aeba_PL:x10eba_TR:x1
0110.0180Total/Positions treated with the CR standardised approacheba_met:mi119xbrli:monetaryItemTypeinstanteba_AP:x42eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x110N/Aeba_PL:x10eba_TR:x1
0110.0190Total/Positions treated with the CR IRB approacheba_met:mi119xbrli:monetaryItemTypeinstanteba_AP:x27eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x110N/Aeba_PL:x10eba_TR:x1
0110.0200Total/Risk weighted exposure amountseba_met:mi793xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x110N/Aeba_PL:x10eba_TR:x1
0110.0210Total/Positions treated with the CR standardised approacheba_met:mi793xbrli:monetaryItemTypeinstanteba_AP:x42eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x110N/Aeba_PL:x10eba_TR:x1
0110.0220Total/Positions treated with the CR IRB approacheba_met:mi793xbrli:monetaryItemTypeinstanteba_AP:x27eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x110N/Aeba_PL:x10eba_TR:x1
0120.0010Of which: SWWR positions/Number of counterpartieseba_met:ii174xbrli:integerItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/Aeba_MC:x1007N/Aeba_PL:x10eba_TR:x1
0120.0020Of which: SWWR positions/Number of transactionseba_met:ii624xbrli:integerItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/Aeba_MC:x1007N/Aeba_PL:x10eba_TR:x1
0120.0030Of which: SWWR positions/Notional amountseba_met:mi170xbrli:monetaryItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/Aeba_MC:x1007N/Aeba_PL:x10eba_TR:x1
0120.0040Of which: SWWR positions/Current market value (CMV), positiveeba_met:mi533xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1007N/Aeba_PL:x10eba_TR:x1
0120.0050Of which: SWWR positions/Current market value (CMV), negativeeba_met:mi740xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1007N/Aeba_PL:x10eba_TR:x1
0120.0060Of which: SWWR positions/Variation margin (VM), receivedeba_met:mi780xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/Aeba_MC:x409eba_MC:x1007N/Aeba_PL:x10eba_TR:x1
0120.0070Of which: SWWR positions/Variation margin (VM), postedeba_met:mi780xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/Aeba_MC:x415N/Aeba_MC:x1007N/Aeba_PL:x10eba_TR:x1
0120.0080Of which: SWWR positions/Net independent collateral amount (NICA), receivedeba_met:mi781xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/Aeba_MC:x409eba_MC:x1007N/Aeba_PL:x10eba_TR:x1
0120.0090Of which: SWWR positions/Net independent collateral amount (NICA), postedeba_met:mi781xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/Aeba_MC:x415N/Aeba_MC:x1007N/Aeba_PL:x10eba_TR:x1
0120.0100Of which: SWWR positions/Replacement cost (RC)eba_met:mi650xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1007N/Aeba_PL:x10eba_TR:x1
0120.0110Of which: SWWR positions/Potential future exposure (PFE)eba_met:mi430xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1007N/Aeba_PL:x10eba_TR:x1
0120.0120Of which: SWWR positions/Current exposureeba_met:mi782xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1007N/Aeba_PL:x10eba_TR:x1
0120.0130Of which: SWWR positions/EEPEeba_met:mi783xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1007N/Aeba_PL:x10eba_TR:x1
0120.0140Of which: SWWR positions/Alpha used for computing regulatory exposure valueeba_met:mi784xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1007N/Aeba_PL:x10eba_TR:x1
0120.0150Of which: SWWR positions/Exposure value pre-CRMeba_met:mi118xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1007N/Aeba_PL:x10eba_TR:x1
0120.0160Of which: SWWR positions/Exposure value post-CRMeba_met:mi116xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1007N/Aeba_PL:x10eba_TR:x1
0120.0170Of which: SWWR positions/Exposure valueeba_met:mi119xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1007N/Aeba_PL:x10eba_TR:x1
0120.0180Of which: SWWR positions/Positions treated with the CR standardised approacheba_met:mi119xbrli:monetaryItemTypeinstanteba_AP:x42eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1007N/Aeba_PL:x10eba_TR:x1
0120.0190Of which: SWWR positions/Positions treated with the CR IRB approacheba_met:mi119xbrli:monetaryItemTypeinstanteba_AP:x27eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1007N/Aeba_PL:x10eba_TR:x1
0120.0200Of which: SWWR positions/Risk weighted exposure amountseba_met:mi793xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1007N/Aeba_PL:x10eba_TR:x1
0120.0210Of which: SWWR positions/Positions treated with the CR standardised approacheba_met:mi793xbrli:monetaryItemTypeinstanteba_AP:x42eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1007N/Aeba_PL:x10eba_TR:x1
0120.0220Of which: SWWR positions/Positions treated with the CR IRB approacheba_met:mi793xbrli:monetaryItemTypeinstanteba_AP:x27eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1007N/Aeba_PL:x10eba_TR:x1
0130.0010Margined business/Number of counterpartieseba_met:ii174xbrli:integerItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/Aeba_MC:x1008N/Aeba_PL:x10eba_TR:x1
0130.0020Margined business/Number of transactionseba_met:ii624xbrli:integerItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/Aeba_MC:x1008N/Aeba_PL:x10eba_TR:x1
0130.0030Margined business/Notional amountseba_met:mi170xbrli:monetaryItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/Aeba_MC:x1008N/Aeba_PL:x10eba_TR:x1
0130.0040Margined business/Current market value (CMV), positiveeba_met:mi533xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1008N/Aeba_PL:x10eba_TR:x1
0130.0050Margined business/Current market value (CMV), negativeeba_met:mi740xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1008N/Aeba_PL:x10eba_TR:x1
0130.0060Margined business/Variation margin (VM), receivedeba_met:mi780xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/Aeba_MC:x409eba_MC:x1008N/Aeba_PL:x10eba_TR:x1
0130.0070Margined business/Variation margin (VM), postedeba_met:mi780xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/Aeba_MC:x415N/Aeba_MC:x1008N/Aeba_PL:x10eba_TR:x1
0130.0080Margined business/Net independent collateral amount (NICA), receivedeba_met:mi781xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/Aeba_MC:x409eba_MC:x1008N/Aeba_PL:x10eba_TR:x1
0130.0090Margined business/Net independent collateral amount (NICA), postedeba_met:mi781xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/Aeba_MC:x415N/Aeba_MC:x1008N/Aeba_PL:x10eba_TR:x1
0130.0100Margined business/Replacement cost (RC)eba_met:mi650xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1008N/Aeba_PL:x10eba_TR:x1
0130.0110Margined business/Potential future exposure (PFE)eba_met:mi430xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1008N/Aeba_PL:x10eba_TR:x1
0130.0120Margined business/Current exposureeba_met:mi782xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1008N/Aeba_PL:x10eba_TR:x1
0130.0130Margined business/EEPEeba_met:mi783xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1008N/Aeba_PL:x10eba_TR:x1
0130.0140Margined business/Alpha used for computing regulatory exposure valueeba_met:mi784xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1008N/Aeba_PL:x10eba_TR:x1
0130.0150Margined business/Exposure value pre-CRMeba_met:mi118xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1008N/Aeba_PL:x10eba_TR:x1
0130.0160Margined business/Exposure value post-CRMeba_met:mi116xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1008N/Aeba_PL:x10eba_TR:x1
0130.0170Margined business/Exposure valueeba_met:mi119xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1008N/Aeba_PL:x10eba_TR:x1
0130.0180Margined business/Positions treated with the CR standardised approacheba_met:mi119xbrli:monetaryItemTypeinstanteba_AP:x42eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1008N/Aeba_PL:x10eba_TR:x1
0130.0190Margined business/Positions treated with the CR IRB approacheba_met:mi119xbrli:monetaryItemTypeinstanteba_AP:x27eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1008N/Aeba_PL:x10eba_TR:x1
0130.0200Margined business/Risk weighted exposure amountseba_met:mi793xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1008N/Aeba_PL:x10eba_TR:x1
0130.0210Margined business/Positions treated with the CR standardised approacheba_met:mi793xbrli:monetaryItemTypeinstanteba_AP:x42eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1008N/Aeba_PL:x10eba_TR:x1
0130.0220Margined business/Positions treated with the CR IRB approacheba_met:mi793xbrli:monetaryItemTypeinstanteba_AP:x27eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1008N/Aeba_PL:x10eba_TR:x1
0140.0010Unmargined business/Number of counterpartieseba_met:ii174xbrli:integerItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/Aeba_MC:x1009N/Aeba_PL:x10eba_TR:x1
0140.0020Unmargined business/Number of transactionseba_met:ii624xbrli:integerItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/Aeba_MC:x1009N/Aeba_PL:x10eba_TR:x1
0140.0030Unmargined business/Notional amountseba_met:mi170xbrli:monetaryItemTypeinstantN/Aeba_BA:x17eba_CT:x81N/AN/AN/Aeba_MC:x1009N/Aeba_PL:x10eba_TR:x1
0140.0040Unmargined business/Current market value (CMV), positiveeba_met:mi533xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1009N/Aeba_PL:x10eba_TR:x1
0140.0050Unmargined business/Current market value (CMV), negativeeba_met:mi740xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1009N/Aeba_PL:x10eba_TR:x1
0140.0060Unmargined business/Variation margin (VM), receivedeba_met:mi780xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/Aeba_MC:x409eba_MC:x1009N/Aeba_PL:x10eba_TR:x1
0140.0070Unmargined business/Variation margin (VM), postedeba_met:mi780xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/Aeba_MC:x415N/Aeba_MC:x1009N/Aeba_PL:x10eba_TR:x1
0140.0080Unmargined business/Net independent collateral amount (NICA), receivedeba_met:mi781xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/Aeba_MC:x409eba_MC:x1009N/Aeba_PL:x10eba_TR:x1
0140.0090Unmargined business/Net independent collateral amount (NICA), postedeba_met:mi781xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/Aeba_MC:x415N/Aeba_MC:x1009N/Aeba_PL:x10eba_TR:x1
0140.0100Unmargined business/Replacement cost (RC)eba_met:mi650xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1009N/Aeba_PL:x10eba_TR:x1
0140.0110Unmargined business/Potential future exposure (PFE)eba_met:mi430xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1009N/Aeba_PL:x10eba_TR:x1
0140.0120Unmargined business/Current exposureeba_met:mi782xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1009N/Aeba_PL:x10eba_TR:x1
0140.0130Unmargined business/EEPEeba_met:mi783xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1009N/Aeba_PL:x10eba_TR:x1
0140.0140Unmargined business/Alpha used for computing regulatory exposure valueeba_met:mi784xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1009N/Aeba_PL:x10eba_TR:x1
0140.0150Unmargined business/Exposure value pre-CRMeba_met:mi118xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1009N/Aeba_PL:x10eba_TR:x1
0140.0160Unmargined business/Exposure value post-CRMeba_met:mi116xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1009N/Aeba_PL:x10eba_TR:x1
0140.0170Unmargined business/Exposure valueeba_met:mi119xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1009N/Aeba_PL:x10eba_TR:x1
0140.0180Unmargined business/Positions treated with the CR standardised approacheba_met:mi119xbrli:monetaryItemTypeinstanteba_AP:x42eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1009N/Aeba_PL:x10eba_TR:x1
0140.0190Unmargined business/Positions treated with the CR IRB approacheba_met:mi119xbrli:monetaryItemTypeinstanteba_AP:x27eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1009N/Aeba_PL:x10eba_TR:x1
0140.0200Unmargined business/Risk weighted exposure amountseba_met:mi793xbrli:monetaryItemTypeinstantN/Aeba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1009N/Aeba_PL:x10eba_TR:x1
0140.0210Unmargined business/Positions treated with the CR standardised approacheba_met:mi793xbrli:monetaryItemTypeinstanteba_AP:x42eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1009N/Aeba_PL:x10eba_TR:x1
0140.0220Unmargined business/Positions treated with the CR IRB approacheba_met:mi793xbrli:monetaryItemTypeinstanteba_AP:x27eba_BA:x9eba_CT:x81N/AN/AN/Aeba_MC:x1009N/Aeba_PL:x10eba_TR:x1

Legal Notice: This demo website displays data, which is publicly available on the Internet. Copyright of all materials is owned by the corresponding data provider. Links to data providers are given for each taxonomy. Data is displayed without any change of lexical information, or identifiers. No part of this website should be considered normative information.

© 2021 by Skynet LLC